Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging

Shih Chieh Hung, Win Ping Deng, Wen K. Yang, Ren Shyan Liu, Chien Chih Lee, Tzu Chi Su, Rue Jen Lin, Den Mei Yang, Chi Wei Chang, Wei Hong Chen, Hon Jian Wei, Juri G. Gelovani

Research output: Contribution to journalArticle

227 Citations (Scopus)

Abstract

The aim of this study was to assess the efficacy human mesenchymal stem cells (hMSC) for targeting microscopic tumors and suicide gene or cytokine gene therapy. Immunodeficient mice were transplanted s.c. with human colon cancer cells of HT-29 Inv2 or CCS line, and 3 to 4 days later, i.v. with "tracer" h MSCs expressing herpes simplex virus type 1 thymidine kinase (HSV1-TK) and enhanced green fluorescent protein (EGFP) reporter genes. Subsequently, these tumors were examined for specificity and magnitude of HSV1-TK+, EGFP+ stem cell engraftment and proliferation in tumor stroma by in vivo positron emission tomography (PET) with 18F-labeled 9-(4-fluoro-3-hydroxymethylbutyl)-guanine ([ 18F]-FHBG). In vivo PET images of tumors growing for 4 weeks showed the presence of HSV1-TK+ tumor stroma with an average of 0.36 ± 0.24% ID/g [18F]-FHBG accumulation. In vivo imaging results were validated by in situ correlative histochemical, immunofluorescent, and cytometric analyses, which revealed EGFP expression in vWF+ and CD31+ endothelial cells of capillaries and larger blood vessels, in germinal layer of dermis and hair follicles proximal to the s.c. tumor site. These differentiated HSV1-TK+, GFP+ endothelial cells had limited proliferative capacity and a short life span of

Original languageEnglish
Pages (from-to)7749-7756
Number of pages8
JournalClinical Cancer Research
Volume11
Issue number21
DOIs
Publication statusPublished - Nov 1 2005

Fingerprint

Mesenchymal Stromal Cells
Positron-Emission Tomography
Thymidine Kinase
Human Herpesvirus 1
Neoplasms
Endothelial Cells
HT29 Cells
Hair Follicle
Dermis
Reporter Genes
Genetic Therapy
Colonic Neoplasms
Suicide
Blood Vessels
Stem Cells
Cell Proliferation
Cytokines
Genes
enhanced green fluorescent protein

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. / Hung, Shih Chieh; Deng, Win Ping; Yang, Wen K.; Liu, Ren Shyan; Lee, Chien Chih; Su, Tzu Chi; Lin, Rue Jen; Yang, Den Mei; Chang, Chi Wei; Chen, Wei Hong; Wei, Hon Jian; Gelovani, Juri G.

In: Clinical Cancer Research, Vol. 11, No. 21, 01.11.2005, p. 7749-7756.

Research output: Contribution to journalArticle

Hung, Shih Chieh ; Deng, Win Ping ; Yang, Wen K. ; Liu, Ren Shyan ; Lee, Chien Chih ; Su, Tzu Chi ; Lin, Rue Jen ; Yang, Den Mei ; Chang, Chi Wei ; Chen, Wei Hong ; Wei, Hon Jian ; Gelovani, Juri G. / Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 21. pp. 7749-7756.
@article{fbc46234e10f49d8948207cec2594ef8,
title = "Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging",
abstract = "The aim of this study was to assess the efficacy human mesenchymal stem cells (hMSC) for targeting microscopic tumors and suicide gene or cytokine gene therapy. Immunodeficient mice were transplanted s.c. with human colon cancer cells of HT-29 Inv2 or CCS line, and 3 to 4 days later, i.v. with {"}tracer{"} h MSCs expressing herpes simplex virus type 1 thymidine kinase (HSV1-TK) and enhanced green fluorescent protein (EGFP) reporter genes. Subsequently, these tumors were examined for specificity and magnitude of HSV1-TK+, EGFP+ stem cell engraftment and proliferation in tumor stroma by in vivo positron emission tomography (PET) with 18F-labeled 9-(4-fluoro-3-hydroxymethylbutyl)-guanine ([ 18F]-FHBG). In vivo PET images of tumors growing for 4 weeks showed the presence of HSV1-TK+ tumor stroma with an average of 0.36 ± 0.24{\%} ID/g [18F]-FHBG accumulation. In vivo imaging results were validated by in situ correlative histochemical, immunofluorescent, and cytometric analyses, which revealed EGFP expression in vWF+ and CD31+ endothelial cells of capillaries and larger blood vessels, in germinal layer of dermis and hair follicles proximal to the s.c. tumor site. These differentiated HSV1-TK+, GFP+ endothelial cells had limited proliferative capacity and a short life span of",
author = "Hung, {Shih Chieh} and Deng, {Win Ping} and Yang, {Wen K.} and Liu, {Ren Shyan} and Lee, {Chien Chih} and Su, {Tzu Chi} and Lin, {Rue Jen} and Yang, {Den Mei} and Chang, {Chi Wei} and Chen, {Wei Hong} and Wei, {Hon Jian} and Gelovani, {Juri G.}",
year = "2005",
month = "11",
day = "1",
doi = "10.1158/1078-0432.CCR-05-0876",
language = "English",
volume = "11",
pages = "7749--7756",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging

AU - Hung, Shih Chieh

AU - Deng, Win Ping

AU - Yang, Wen K.

AU - Liu, Ren Shyan

AU - Lee, Chien Chih

AU - Su, Tzu Chi

AU - Lin, Rue Jen

AU - Yang, Den Mei

AU - Chang, Chi Wei

AU - Chen, Wei Hong

AU - Wei, Hon Jian

AU - Gelovani, Juri G.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - The aim of this study was to assess the efficacy human mesenchymal stem cells (hMSC) for targeting microscopic tumors and suicide gene or cytokine gene therapy. Immunodeficient mice were transplanted s.c. with human colon cancer cells of HT-29 Inv2 or CCS line, and 3 to 4 days later, i.v. with "tracer" h MSCs expressing herpes simplex virus type 1 thymidine kinase (HSV1-TK) and enhanced green fluorescent protein (EGFP) reporter genes. Subsequently, these tumors were examined for specificity and magnitude of HSV1-TK+, EGFP+ stem cell engraftment and proliferation in tumor stroma by in vivo positron emission tomography (PET) with 18F-labeled 9-(4-fluoro-3-hydroxymethylbutyl)-guanine ([ 18F]-FHBG). In vivo PET images of tumors growing for 4 weeks showed the presence of HSV1-TK+ tumor stroma with an average of 0.36 ± 0.24% ID/g [18F]-FHBG accumulation. In vivo imaging results were validated by in situ correlative histochemical, immunofluorescent, and cytometric analyses, which revealed EGFP expression in vWF+ and CD31+ endothelial cells of capillaries and larger blood vessels, in germinal layer of dermis and hair follicles proximal to the s.c. tumor site. These differentiated HSV1-TK+, GFP+ endothelial cells had limited proliferative capacity and a short life span of

AB - The aim of this study was to assess the efficacy human mesenchymal stem cells (hMSC) for targeting microscopic tumors and suicide gene or cytokine gene therapy. Immunodeficient mice were transplanted s.c. with human colon cancer cells of HT-29 Inv2 or CCS line, and 3 to 4 days later, i.v. with "tracer" h MSCs expressing herpes simplex virus type 1 thymidine kinase (HSV1-TK) and enhanced green fluorescent protein (EGFP) reporter genes. Subsequently, these tumors were examined for specificity and magnitude of HSV1-TK+, EGFP+ stem cell engraftment and proliferation in tumor stroma by in vivo positron emission tomography (PET) with 18F-labeled 9-(4-fluoro-3-hydroxymethylbutyl)-guanine ([ 18F]-FHBG). In vivo PET images of tumors growing for 4 weeks showed the presence of HSV1-TK+ tumor stroma with an average of 0.36 ± 0.24% ID/g [18F]-FHBG accumulation. In vivo imaging results were validated by in situ correlative histochemical, immunofluorescent, and cytometric analyses, which revealed EGFP expression in vWF+ and CD31+ endothelial cells of capillaries and larger blood vessels, in germinal layer of dermis and hair follicles proximal to the s.c. tumor site. These differentiated HSV1-TK+, GFP+ endothelial cells had limited proliferative capacity and a short life span of

UR - http://www.scopus.com/inward/record.url?scp=27744493024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744493024&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-05-0876

DO - 10.1158/1078-0432.CCR-05-0876

M3 - Article

VL - 11

SP - 7749

EP - 7756

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 21

ER -